Skip to content
2000
Volume 8, Issue 1
  • ISSN: 1573-4129
  • E-ISSN: 1875-676X

Abstract

Deguelin is the major active ingredient and principal component in cube resin, derived from Lonchocarpus utilis and used as a botanical insecticide and pesticide in Africa, South America and China. A growing body of evidence indicates that deguelin has a very strong anti-tumor effect on malignant cells without compromising normal cells. As a complex natural extract, deguelin interacts with various molecular targets to exert its anti-tumor properties at nanomolar levels. This current review delineates the molecular mechanism of the anti-tumor activities of deguelin in malignancies. Our research shows that the multiple and extensive biological effects of deguelin are mediated via interactions with target points involved in cell proliferation pathways (cyclin D1, pRb), cell apoptosis pathways (NF-κB, IκBα, Bcl-2, Bcl-xl, survivin), the nucleophosmin and nucleoporins pathways (Nup88, Nup98, Nup214), as well as through the regulation of steroid receptor co-activator SRC-3 and DNA Topoisomerase. In addition, deguelin holds a promising efficacy for reversing drug resistance.

Loading

Article metrics loading...

/content/journals/cpa/10.2174/157341212798995467
2012-02-01
2025-09-12
Loading full text...

Full text loading...

/content/journals/cpa/10.2174/157341212798995467
Loading

  • Article Type:
    Research Article
Keyword(s): Anti-tumor; Bcl-2; Bcl-xl; Cyclin D1; Deguelin; IκBα; NF-κB; NPM; NUPs; pRb; SRC-3; Survivin
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test